KRX-0502 (Ferric Citrate) for the Treatment of IDA in Adult Subjects With NDD-CKD

NCT02268994 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
234
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Keryx Biopharmaceuticals